Bailard, Inc. Ocular Therapeutix, Inc Transaction History

Bailard, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2017 Jan 29, 2018	SELL	N/A	-100,000 Reduced 40.53%	146,752 $1.36 Million
Q4 2016 Jan 29, 2018	SELL	N/A	-68,000 Reduced 21.6%	246,752 $0
Q3 2016 Jan 29, 2018	BUY	N/A	95,000 Added 43.23%	314,752 $2.16 Million
Q1 2016 Jan 29, 2018	BUY	N/A	127,752 Added 138.86%	219,752 $2.12 Million
Q3 2015 Jan 29, 2018	BUY	N/A	37,000 Added 67.27%	92,000 $1.29 Million
Q1 2015 Jan 29, 2018	BUY	N/A	55,000	55,000 $2.31 Million

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $673M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.